Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
$15.41
+1.2%
$15.50
$13.65
$15.98
N/AN/A88,001 shs50,717 shs
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
$0.29
$0.15
$0.84
$10.93M1.3160,047 shs1.27 million shs
Newfield Exploration stock logo
NFX
Newfield Exploration
$17.07
$0.00
$12.45
$31.46
$3.43B1.858.80 million shsN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.20
-0.1%
$11.11
$10.52
$11.92
$242.14M-0.0162,779 shs16,141 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
-0.85%+0.46%-3.97%-0.46%+3.82%
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.00%0.00%0.00%0.00%-75.46%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.00%0.00%0.00%0.00%0.00%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
+0.09%+0.22%+0.90%+1.72%+6.56%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.7977 of 5 stars
3.50.00.00.00.01.70.0
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
N/AN/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
3.00
Buy$2.75∞ Upside
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
$23.32MN/AN/AN/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/AN/AN/AN/A$0.32 per shareN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
$1.77B1.94$4.50 per share3.79$7.05 per share2.42
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/A$0.40 per share28.14($0.64) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
N/AN/A0.00N/AN/AN/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
-$7.60M-$0.09N/AN/AN/AN/A-42.68%-35.17%N/A
Newfield Exploration stock logo
NFX
Newfield Exploration
$427M$2.157.945.170.3721.14%43.65%13.21%N/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.44MN/A0.00N/AN/A-65.59%5.02%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
$1.489.60%N/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/A

Latest RENE, MDNA, NFX, and BIT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
Monthly$0.12409.48%4/12/20244/15/20244/30/2024
3/1/2024
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
Monthly$0.12409.55%3/14/20243/15/20243/28/2024
2/1/2024
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
Monthly$0.12409.63%2/14/20242/15/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
N/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/A
9.57
9.57
Newfield Exploration stock logo
NFX
Newfield Exploration
1.30
0.72
0.70
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A
0.22
0.22

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Multi-Sector Income Trust stock logo
BIT
BlackRock Multi-Sector Income Trust
N/AN/AN/ANot Optionable
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
1669.64 million46.59 millionNot Optionable
Newfield Exploration stock logo
NFX
Newfield Exploration
N/A200.93 millionN/AOptionable
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A21.62 million17.30 millionNot Optionable

RENE, MDNA, NFX, and BIT Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BlackRock Multi-Sector Income Trust logo

BlackRock Multi-Sector Income Trust

NYSE:BIT
BlackRock Multi-Sector Income Trust is a close ended fixed income mutual fund launched by BlackRock, Inc. It is co-managed by BlackRock Advisors, LLC and BlackRock (Singapore) Limited. The fund invests in fixed income markets. It invests primarily in loan and debt instruments and other investments with similar economic characteristic. BlackRock Multi-Sector Income Trust was formed on February 25, 2013 and is domiciled in the United States.
Medicenna Therapeutics logo

Medicenna Therapeutics

NASDAQ:MDNA
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
Newfield Exploration logo

Newfield Exploration

NYSE:NFX
Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.
Cartesian Growth Co. II logo

Cartesian Growth Co. II

NASDAQ:RENE
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.